{"DataElement":{"publicId":"7550061","version":"1","preferredName":"Pharmacogenomics Findings Domain Performed CD23 Antigen Biomarker Test Performed Result Percentage Number","preferredDefinition":"A question that asks for the result of positive CD23 biomarker test expressed in percentage.","longName":"PF_PFORRES_CD23PCT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7550058","version":"1","preferredName":"Pharmacogenomics Findings Domain Performed CD23 Antigen Biomarker Test Performed","preferredDefinition":"A findings domain for gene expression and genetic variation assessments._Executed and carried through to completion._Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI)._A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention._A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._To execute and carry through to completion.","longName":"6944198v1.0:7550068v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6944198","version":"1","preferredName":"Pharmacogenomics Findings Domain","preferredDefinition":"A findings domain for gene expression and genetic variation assessments.","longName":"C111289","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacogenomics Findings Domain","conceptCode":"C111289","definition":"A findings domain for gene expression and genetic variation assessments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9365C759-3409-7B96-E053-F662850AD5BA","latestVersionIndicator":"Yes","beginDate":"2019-09-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-09-25","modifiedBy":"ONEDATA","dateModified":"2019-09-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7550068","version":"1","preferredName":"CD23 Antigen Biomarker Test Performed","preferredDefinition":"Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI).:A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.:A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.:Executed and carried through to completion.","longName":"C0162826:C16342:C47891:C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD23 Antigen","conceptCode":"C0162826","definition":"Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI).","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"3"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Test","conceptCode":"C47891","definition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8F57CD3-D5F9-2B23-E053-4EBD850A1301","latestVersionIndicator":"Yes","beginDate":"2021-01-15","endDate":null,"createdBy":"GALITG","dateCreated":"2021-01-15","modifiedBy":"ONEDATA","dateModified":"2021-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8F5DEE7-FC41-5C76-E053-4EBD850AAD69","latestVersionIndicator":"Yes","beginDate":"2021-01-15","endDate":null,"createdBy":"GALITG","dateCreated":"2021-01-15","modifiedBy":"GALITG","dateModified":"2021-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2406660","version":"1","preferredName":"Result Percentage Number","preferredDefinition":"The results of a biomarker test recorded as a percentage.","longName":"BIOM_TST_RSL_PTG_NUM","context":"DCP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"6","minValue":null,"maxValue":null,"decimalPlace":"3","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2406659","version":"1","preferredName":"Result Percentage Number","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.:Percentage; a fraction or ratio with 100 understood as the denominator.:Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"C20200:C25613:C25337","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0149E795-459B-054B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"ONEDATA","dateModified":"2005-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0149E795-459C-054B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"MAESKEB","dateModified":"2005-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Result in percentage:","type":"Preferred Question Text","description":"Result in percentage:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8F5DEE7-FC5F-5C76-E053-4EBD850AAD69","latestVersionIndicator":"Yes","beginDate":"2021-01-15","endDate":null,"createdBy":"GALITG","dateCreated":"2021-01-15","modifiedBy":"GALITG","dateModified":"2021-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}